Jun Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jun Zhang has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Xiaoji Luo
The First Affiliated Hospital of Chongqing Medical University
11 shared publications - Ningdao Li
Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, China
6 shared publications Xiao Qu
Department of Orthopaedic Surgery, Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine/Orthopaedic Research Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China
5 shared publicationsRunhan Zhao
Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, PR China
4 shared publicationsYafei Zhu
Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, China
4 shared publicationsJingtao Xu
Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, People's Republic of China
3 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 65, 246-267
The miR-212-3p/transferrin axis promotes bone regeneration by modulating iron homeostasis through Schwann cell Exosome-BMSCs communication
Functional bone regeneration relies on cross talk between nerves and bone, yet the regulatory mechanisms linking Schwann cells (SCs) to osteoporotic bone marrow mesenchymal stem cells (OP-BMSCs) remain unclear. This study demonstrated that SC-Exosomes (Exos) promoted the osteogenic differentiation of OP-BMSCs, and miRNA-mRNA sequencing revealed that SC-Exos, which contained the key mediator miR-212-3p, facilitated osteogenesis by suppressing the ferroptosis pathway in OP-BMSCs. miR-212-3p overexpression combined with transferrin (TF) knockdown or overexpression confirmed that miR-212-3p suppresses TF expression and validated the role of the miR-212-3p/TF axis, which maintained iron homeostasis in BMSCs, alleviated iron overload and oxidative stress, and promoted osteogenic differentiation. Furthermore, an injectable SC-Exos-loaded gelatin methacrylate hydrogel (SC-Exos/GelMA) targeting BMSCs was constructed. In vitro, SC-Exos/GelMA enabled sustained release of Exos and promoted BMSCs osteogenesis. In vivo, SC-Exos/GelMA downregulated TF expression via the miR-212-3p/TF axis, mitigated ferroptosis, restored iron homeostasis, accelerated angiogenesis/neurogenesis, and promoted bone regeneration. This study not only elucidated the role of the miR-212-3p/TF axis in the modulation of BMSCs iron homeostasis, but also constructed an injectable SC-Exos/GelMA hydrogel for bone regeneration, offering mechanistic insights and a translational therapeutic strategy for bone regeneration in clinic.
- 1 November 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 65, 246-267
Open AccessThe miR-212-3p/transferrin axis promotes bone regeneration by modulating iron homeostasis through Schwann cell Exosome-BMSCs communication
Functional bone regeneration relies on cross talk between nerves and bone, yet the regulatory mechanisms linking Schwann cells (SCs) to osteoporotic bone marrow mesenchymal stem cells (OP-BMSCs) remain unclear. This study demonstrated that SC-Exosomes (Exos) promoted the osteogenic differentiation of OP-BMSCs, and miRNA-mRNA sequencing revealed that SC-Exos, which contained the key mediator miR-212-3p, facilitated osteogenesis by suppressing the ferroptosis pathway in OP-BMSCs. miR-212-3p overexpression combined with transferrin (TF) knockdown or overexpression confirmed that miR-212-3p suppresses TF expression and validated the role of the miR-212-3p/TF axis, which maintained iron homeostasis in BMSCs, alleviated iron overload and oxidative stress, and promoted osteogenic differentiation. Furthermore, an injectable SC-Exos-loaded gelatin methacrylate hydrogel (SC-Exos/GelMA) targeting BMSCs was constructed. In vitro, SC-Exos/GelMA enabled sustained release of Exos and promoted BMSCs osteogenesis. In vivo, SC-Exos/GelMA downregulated TF expression via the miR-212-3p/TF axis, mitigated ferroptosis, restored iron homeostasis, accelerated angiogenesis/neurogenesis, and promoted bone regeneration. This study not only elucidated the role of the miR-212-3p/TF axis in the modulation of BMSCs iron homeostasis, but also constructed an injectable SC-Exos/GelMA hydrogel for bone regeneration, offering mechanistic insights and a translational therapeutic strategy for bone regeneration in clinic.
- Open Access
- 14 May 2026
- Published by Elsevier in Regenerative Therapy
- Vol. 32, 101124
Multidimensional bibliometric analysis and global trends in the nervous system’s role in bone regeneration
- 14 May 2026
- Published by Elsevier in Regenerative Therapy
- Vol. 32, 101124
Open AccessMultidimensional bibliometric analysis and global trends in the nervous system’s role in bone regeneration
- Open Access
- 31 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103067
CGRP-empowered stem cell sheet/short nanofiber sponge via enhancing neurovascular coupling for bone regeneration
- 31 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103067
Open AccessCGRP-empowered stem cell sheet/short nanofiber sponge via enhancing neurovascular coupling for bone regeneration
- 29 March 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 359, 151700
Lyophilized platelet-rich fibrin functionalized injectable hydrogel microspheres for alleviating osteoarthritis in a rat model
- 29 March 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 359, 151700
Lyophilized platelet-rich fibrin functionalized injectable hydrogel microspheres for alleviating osteoarthritis in a rat model
- Open Access
- 1 January 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (1) , 101630
Veratramine influences the proliferation of human osteosarcoma cells through modulating the PI3K/AKT signaling cascade
Osteosarcoma (OS) is a highly aggressive tumor with a propensity for early metastasis. Current treatment methods, such as chemotherapy, often bring significant side effects, affecting patients' quality of life. Veratramine (VER), an alkaloid derived from the American lily plant, has shown potential in cancer treatment. This study looks at the effects and mechanisms of VER on osteosarcoma. VER's impact was assessed using a variety of procedures, including crystal violet staining, the CCK-8 assay, and the colony formation assay, which measured cell proliferation. Wound healing assay and transwell assay were employed to evaluate the migration and invasion of osteosarcoma cells. Hoechst33258 staining, flow cytometry, and transmission electron microscopy were used to investigate apoptosis. Protein expression was assessed using western blotting and immunofluorescence. Blood tests and hematoxylin-eosin staining were used to establish VER's in vivo safety, and its effectiveness was proven using an orthotopic tumor model. The results showed that VER greatly decreased osteosarcoma cell growth, migration, and invasion while inducing apoptosis. Animal tests confirmed these findings, confirming VER's high efficacy and safety in vivo. VER might function by inhibiting the PI3K/AKT signaling pathway. To sum up, VER shows promise in treating osteosarcoma by exhibiting significant anti-tumor activity in laboratory and animal studies, likely through the regulation of the PI3K/AKT signaling pathway.
- 1 January 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (1) , 101630
Open AccessVeratramine influences the proliferation of human osteosarcoma cells through modulating the PI3K/AKT signaling cascade
Osteosarcoma (OS) is a highly aggressive tumor with a propensity for early metastasis. Current treatment methods, such as chemotherapy, often bring significant side effects, affecting patients' quality of life. Veratramine (VER), an alkaloid derived from the American lily plant, has shown potential in cancer treatment. This study looks at the effects and mechanisms of VER on osteosarcoma. VER's impact was assessed using a variety of procedures, including crystal violet staining, the CCK-8 assay, and the colony formation assay, which measured cell proliferation. Wound healing assay and transwell assay were employed to evaluate the migration and invasion of osteosarcoma cells. Hoechst33258 staining, flow cytometry, and transmission electron microscopy were used to investigate apoptosis. Protein expression was assessed using western blotting and immunofluorescence. Blood tests and hematoxylin-eosin staining were used to establish VER's in vivo safety, and its effectiveness was proven using an orthotopic tumor model. The results showed that VER greatly decreased osteosarcoma cell growth, migration, and invasion while inducing apoptosis. Animal tests confirmed these findings, confirming VER's high efficacy and safety in vivo. VER might function by inhibiting the PI3K/AKT signaling pathway. To sum up, VER shows promise in treating osteosarcoma by exhibiting significant anti-tumor activity in laboratory and animal studies, likely through the regulation of the PI3K/AKT signaling pathway.
- Open Access
- 15 December 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 37 (1)
A novel vascularized hydrogel by encapsulation of lyophilized platelet-rich fibrin into gelatin methacryloyl hydrogel for bone regeneration
Vascularized osteogenesis is crucial for bone regeneration. Platelet-rich fibrin (PRF) includs many growth factors, of which VEGF plays the significant role in vascularization. No study has investigated the effect of lyophilized platelet-rich fibrin (Ly-PRF) combined with gelatin methacryloyl (GelMA) on the repair of bone defects. We first prepared fresh PRF by one-step centrifugation method. Then, we constructed Ly-PRF by lyophilization. Afterwards, GelMA was synthesized by chemical synthesis method and GelMA hydrogel was prepared by photo-crosslinking method. Finally, Ly-PRF was encapsulated into GelMA hydrogel to construct GelMA@Ly-PRF hydrogel and used in vitro and in vivo to explore its effect on calvarial regeneration of rats. The fresh PRF had good elasticity. GelMA was synthesized by chemical synthesis method and GelMA hydrogel was formed by blue light-irradiation of GelMA solution. After encapsulation of Ly-PRF into GelMA hydrogel, VEGF in Ly-PRF could slowly and sustainably release for continuous 21 days. In vitro, the GelMA@Ly-PRF hydrogel had high swelling property and porous structure. What’s more, it had good cytocompatibility and was capable of promoting angiopoiesis of human umbilical vein endothelial cells (HUVECs). In vivo, the GelMA@Ly-PRF hydrogel could facilitate to repair calvarial defects of rats by promoting formation of new blood vessel during the process of bone healing, evidenced by Micro-CT, H&E staining, Masson’s staining and immunohistochemical staining of CD31 and OPN. Encapsulation of Ly-PRF into a GelMA hydrogel could promote bone regeneration of rats.
- 15 December 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 37 (1)
Open AccessA novel vascularized hydrogel by encapsulation of lyophilized platelet-rich fibrin into gelatin methacryloyl hydrogel for bone regeneration
Vascularized osteogenesis is crucial for bone regeneration. Platelet-rich fibrin (PRF) includs many growth factors, of which VEGF plays the significant role in vascularization. No study has investigated the effect of lyophilized platelet-rich fibrin (Ly-PRF) combined with gelatin methacryloyl (GelMA) on the repair of bone defects. We first prepared fresh PRF by one-step centrifugation method. Then, we constructed Ly-PRF by lyophilization. Afterwards, GelMA was synthesized by chemical synthesis method and GelMA hydrogel was prepared by photo-crosslinking method. Finally, Ly-PRF was encapsulated into GelMA hydrogel to construct GelMA@Ly-PRF hydrogel and used in vitro and in vivo to explore its effect on calvarial regeneration of rats. The fresh PRF had good elasticity. GelMA was synthesized by chemical synthesis method and GelMA hydrogel was formed by blue light-irradiation of GelMA solution. After encapsulation of Ly-PRF into GelMA hydrogel, VEGF in Ly-PRF could slowly and sustainably release for continuous 21 days. In vitro, the GelMA@Ly-PRF hydrogel had high swelling property and porous structure. What’s more, it had good cytocompatibility and was capable of promoting angiopoiesis of human umbilical vein endothelial cells (HUVECs). In vivo, the GelMA@Ly-PRF hydrogel could facilitate to repair calvarial defects of rats by promoting formation of new blood vessel during the process of bone healing, evidenced by Micro-CT, H&E staining, Masson’s staining and immunohistochemical staining of CD31 and OPN. Encapsulation of Ly-PRF into a GelMA hydrogel could promote bone regeneration of rats.
- Open Access
- 22 September 2025
- Vol. 6 (3) , 345-358
The role of Wnt signalling in osteoporosis: A bibliometric analysis
Osteoporosis has long been a key area of medical research, as the Wnt signalling pathway is essential for bone formation and maintaining bone balance. The purpose of this study was to perform a bibliometric analysis of the literature on osteoporosis and Wnt signalling to identify research trends, hot topics, and emerging areas of interest in this field. A visual analysis of the literature on osteoporosis and Wnt signalling offers a clearer perspective on the current research landscape, highlighting key topics and emerging trends in this area. The present study analysed publications related to osteoporosis and Wnt signalling from January 1, 2002 to December 31, 2021, using data from the Web of Science Core Collection. A total of 1553 publications were examined via tools, such as Microsoft Excel, CiteSpace, Vosviewer, and the Bibliometrics online analysis platform. The findings indicated that China has the highest number of publications in this area, with 489 articles. Warman Mathew’s work has the most citations, totalling 1031 articles, and the journal Bone has published the most articles, with 89 publications. Current research in this field has focused primarily on osteogenesis, metabolism, fractures, and osteoblasts. The present study highlights the significant role of Wnt signalling in bone homeostasis and disease, suggesting that future research will explore novel metabolic therapies for osteoporosis by targeting the Wnt signalling pathway with drugs.
- 22 September 2025
- Vol. 6 (3) , 345-358
Open AccessThe role of Wnt signalling in osteoporosis: A bibliometric analysis
Osteoporosis has long been a key area of medical research, as the Wnt signalling pathway is essential for bone formation and maintaining bone balance. The purpose of this study was to perform a bibliometric analysis of the literature on osteoporosis and Wnt signalling to identify research trends, hot topics, and emerging areas of interest in this field. A visual analysis of the literature on osteoporosis and Wnt signalling offers a clearer perspective on the current research landscape, highlighting key topics and emerging trends in this area. The present study analysed publications related to osteoporosis and Wnt signalling from January 1, 2002 to December 31, 2021, using data from the Web of Science Core Collection. A total of 1553 publications were examined via tools, such as Microsoft Excel, CiteSpace, Vosviewer, and the Bibliometrics online analysis platform. The findings indicated that China has the highest number of publications in this area, with 489 articles. Warman Mathew’s work has the most citations, totalling 1031 articles, and the journal Bone has published the most articles, with 89 publications. Current research in this field has focused primarily on osteogenesis, metabolism, fractures, and osteoblasts. The present study highlights the significant role of Wnt signalling in bone homeostasis and disease, suggesting that future research will explore novel metabolic therapies for osteoporosis by targeting the Wnt signalling pathway with drugs.
- 27 June 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (8) , 3549-3556
Thoracic spine metastases from lung cancer with incomplete paralysis treated by endoscopic spinal surgery: a case report
Study Design A case report. Objective Presentation of transpedicular approach for endoscopic spine surgery (ESS) in a patient with thoracic spine metastases from lung cancer with incomplete paralysis. Background The spine is the most colonized site for tumor bone metastases, and approximately 5–10% of patients develop symptoms of nerve and spinal cord compression. Traditional open surgery is the best management strategy to address patients’ neurological symptoms, but its demanding physical status and low clinical benefit in end-stage patients limit its application in spinal metastases. With the accumulation of experience and technological breakthroughs in ESS, this technology has become an ideal choice for palliative treatment of patients with end-stage spinal metastases. Method A patient with thoracic spine metastasis from lung cancer with incomplete paralysis was treated with ESS using a transpedicular approach. Results A patient with lung cancer thoracic spine metastasis with incomplete paralysis was unable to tolerate traditional open surgery due to her physical condition, so our team used the strategy of spinal endoscopic decompression with tumor resection via transpedicular approach to treat him. After the operation, the patient’s pain and neurological symptoms were significantly relieved, and he regained the ability to walk on himself within two months. Moreover, the technique prolonged his survival while safeguarding his quality of life. Conclusion ESS is ideal for patients with end-stage spinal metastases.
- 27 June 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (8) , 3549-3556
Thoracic spine metastases from lung cancer with incomplete paralysis treated by endoscopic spinal surgery: a case report
Study Design A case report. Objective Presentation of transpedicular approach for endoscopic spine surgery (ESS) in a patient with thoracic spine metastases from lung cancer with incomplete paralysis. Background The spine is the most colonized site for tumor bone metastases, and approximately 5–10% of patients develop symptoms of nerve and spinal cord compression. Traditional open surgery is the best management strategy to address patients’ neurological symptoms, but its demanding physical status and low clinical benefit in end-stage patients limit its application in spinal metastases. With the accumulation of experience and technological breakthroughs in ESS, this technology has become an ideal choice for palliative treatment of patients with end-stage spinal metastases. Method A patient with thoracic spine metastasis from lung cancer with incomplete paralysis was treated with ESS using a transpedicular approach. Results A patient with lung cancer thoracic spine metastasis with incomplete paralysis was unable to tolerate traditional open surgery due to her physical condition, so our team used the strategy of spinal endoscopic decompression with tumor resection via transpedicular approach to treat him. After the operation, the patient’s pain and neurological symptoms were significantly relieved, and he regained the ability to walk on himself within two months. Moreover, the technique prolonged his survival while safeguarding his quality of life. Conclusion ESS is ideal for patients with end-stage spinal metastases.
- Open Access
- 17 March 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1552727
Bibliometric and visualized analysis of the applications of exosomes for bone regeneration
Background: Bone defect, a common orthopedic condition, is characterized by a lengthy and impactful treatment period, posing a considerable challenge in clinical settings. Medical technology has advanced notably, and has effectively treated an increasing number of patients with bone defects. Consequently, there has been an explosion of research articles on bone regeneration, including a substantial number on the application of exosomes. Exosomes, especially those derived from stem cells, have been confirmed to be effective in bone regeneration and have garnered widespread attention in the last decade. Therefore, this study conducted a bibliometric analysis on publications related to the application of exosomes for bone regeneration. The objectives are to explore the development history and research hotspots in this field over the past 10 years, predict future development trends, and provide guidance for subsequent research.Methods: The Web of Science Core Collection (WoSCC) database was searched for articles related to exosomes and bone regeneration published from 1 January 2014, to 31 December 2023. The collected literature was analyzed using software such as Microsoft Excel, CiteSpace 6.3R1, VOSviewer 1.6.20, and the bibliometric online platform (https://bibliometric.com).Results: A total of 3,004 articles published by 2,729 institutions from 68 countries were included in this study. The number of articles on the application of exosomes for bone regeneration has increased annually over the last decade. China was the most prolific country in this field, with a total of 1,468 papers; Shanghai Jiao Tong University (China) was the institution with the highest number of publications (117 publications). In terms of authors, Xin Wang, Yi Zhang, and Yang Wang were the three who published the highest number of papers, with 14 papers each. Co-citation analysis revealed that the article published by Valadi H in 2007 has the highest number of co-citations (270 times of quotation). Additionally, most research hotspots focused on the function of exosomes and the mechanism of action. Furthermore, the importance of osteoblast differentiation and angiogenesis in bone regeneration has also garnered significant attention from scholars in this field.Conclusion: This study reviewed the research achievements on the application of exosomes for bone regeneration over the past 10 years, utilizing bibliometric analysis tools. It visualized the countries, institutions, authors, and journals that have made significant contributions to this field, revealed current research hotspots, and finally explored future development trends.
- 17 March 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1552727
Open AccessBibliometric and visualized analysis of the applications of exosomes for bone regeneration
Background: Bone defect, a common orthopedic condition, is characterized by a lengthy and impactful treatment period, posing a considerable challenge in clinical settings. Medical technology has advanced notably, and has effectively treated an increasing number of patients with bone defects. Consequently, there has been an explosion of research articles on bone regeneration, including a substantial number on the application of exosomes. Exosomes, especially those derived from stem cells, have been confirmed to be effective in bone regeneration and have garnered widespread attention in the last decade. Therefore, this study conducted a bibliometric analysis on publications related to the application of exosomes for bone regeneration. The objectives are to explore the development history and research hotspots in this field over the past 10 years, predict future development trends, and provide guidance for subsequent research.Methods: The Web of Science Core Collection (WoSCC) database was searched for articles related to exosomes and bone regeneration published from 1 January 2014, to 31 December 2023. The collected literature was analyzed using software such as Microsoft Excel, CiteSpace 6.3R1, VOSviewer 1.6.20, and the bibliometric online platform (https://bibliometric.com).Results: A total of 3,004 articles published by 2,729 institutions from 68 countries were included in this study. The number of articles on the application of exosomes for bone regeneration has increased annually over the last decade. China was the most prolific country in this field, with a total of 1,468 papers; Shanghai Jiao Tong University (China) was the institution with the highest number of publications (117 publications). In terms of authors, Xin Wang, Yi Zhang, and Yang Wang were the three who published the highest number of papers, with 14 papers each. Co-citation analysis revealed that the article published by Valadi H in 2007 has the highest number of co-citations (270 times of quotation). Additionally, most research hotspots focused on the function of exosomes and the mechanism of action. Furthermore, the importance of osteoblast differentiation and angiogenesis in bone regeneration has also garnered significant attention from scholars in this field.Conclusion: This study reviewed the research achievements on the application of exosomes for bone regeneration over the past 10 years, utilizing bibliometric analysis tools. It visualized the countries, institutions, authors, and journals that have made significant contributions to this field, revealed current research hotspots, and finally explored future development trends.
- Open Access
- 1 January 2025
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2025 (1) , 3279688
DBI Mediates the Progression of Ankylosing Spondylitis by Regulating CD56 dim NK Cells Cytotoxicity Function
Background: Ankylosing spondylitis (AS) is an autoimmune disease characterized by low back stiffness and pain, with no cure and a dearth of therapeutic targets. Methods: Identifying novel AS targets from a list of 5884 druggable genes using weighted gene coexpression network analysis (WGCNA), machine learning, and Mendelian randomization analysis. Investigating the biological functions of the targets through comprehensive bio‐functional analyses; exploring immune‐related functions of the targets based on single‐cell analyses; developing a reliable AS risk prediction model based on the identified targets and clinical data; conducting target drug prediction and molecular docking based on the Enrichr database and the LeDock software. Results: A novel AS target, diazepam binding inhibitor (DBI), was identified from among 5884 druggable genes. Bio‐functional enrichment analysis indicated that this gene plays a key role in AS by modulating lipid metabolism disorders. Furthermore, single‐cell analysis revealed that the gene likely influences the onset or progression of AS by impairing the cytotoxic function of CD56 dim natural killer (NK) cells. Finally, a reliable AS risk prediction model was developed using DBI and clinical data, and several potential therapeutic compounds were identified. Conclusion: In this study, a novel therapeutic target for AS was identified using multiple algorithms, and it was found to be involved in lipid metabolism and cytotoxic function of CD56 dim NK cells. Additionally, a reliable prediction model was developed, and potential therapeutic compounds were identified. In conclusion, this study presents a novel approach for AS treatment.
- 1 January 2025
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2025 (1) , 3279688
Open AccessDBI Mediates the Progression of Ankylosing Spondylitis by Regulating CD56 dim NK Cells Cytotoxicity Function
Background: Ankylosing spondylitis (AS) is an autoimmune disease characterized by low back stiffness and pain, with no cure and a dearth of therapeutic targets. Methods: Identifying novel AS targets from a list of 5884 druggable genes using weighted gene coexpression network analysis (WGCNA), machine learning, and Mendelian randomization analysis. Investigating the biological functions of the targets through comprehensive bio‐functional analyses; exploring immune‐related functions of the targets based on single‐cell analyses; developing a reliable AS risk prediction model based on the identified targets and clinical data; conducting target drug prediction and molecular docking based on the Enrichr database and the LeDock software. Results: A novel AS target, diazepam binding inhibitor (DBI), was identified from among 5884 druggable genes. Bio‐functional enrichment analysis indicated that this gene plays a key role in AS by modulating lipid metabolism disorders. Furthermore, single‐cell analysis revealed that the gene likely influences the onset or progression of AS by impairing the cytotoxic function of CD56 dim natural killer (NK) cells. Finally, a reliable AS risk prediction model was developed using DBI and clinical data, and several potential therapeutic compounds were identified. Conclusion: In this study, a novel therapeutic target for AS was identified using multiple algorithms, and it was found to be involved in lipid metabolism and cytotoxic function of CD56 dim NK cells. Additionally, a reliable prediction model was developed, and potential therapeutic compounds were identified. In conclusion, this study presents a novel approach for AS treatment.